May 09, 2024
3 min watch
Save
VIDEO: Intravitreal implant for wet AMD shows positive results in three clinical trials
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Pravin U. Dugel, MD, of Ocular Therapeutix, overviews clinical results for Axpaxli, an axitinib implant for wet age-related macular degeneration.
Dugel discussed promising data across three clinical trials.
“We have already randomized for the SOL-1 study, which is a pivotal phase 3 study, and we’re very excited to report further results in the near-term,” Dugel said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Dugel reports being the executive chair, president and CEO at Ocular Therapeutix.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.